Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Clin Ter ; 160(2): 125-7, 2009.
Article in English | MEDLINE | ID: mdl-19452101

ABSTRACT

Posterior cerebral artery (PCA) territory infarcts account for only 5-10% of all infarcts in stroke registries. Moreover, the clinical features and etiology of such infarcts have not been studied as extensively as those in other vascular territories.We describe two patients with recurrent episodes of visual symptoms and headache due to probable transitory PCA vasospasm. MR angiography in the acute phase revealed incomplete visualization of PCA, conventional MRI showed mild T2 signal alterations and MR perfusion showed the presence of marked hypoperfusion in the same regions. Diffusion weighted MR images were normal. All these findings resolved after therapy. These cases suggest that reversible signal alterations associated with reversible vessel and perfusion abnormalities may be observed in patients with visual symptoms and headache. Normal DWI-MR may help distinguish these patients from those affected by non-reversible ischemic attacks.


Subject(s)
Headache/etiology , Infarction, Posterior Cerebral Artery/pathology , Magnetic Resonance Imaging , Vasospasm, Intracranial/pathology , Vision Disorders/etiology , Acute Disease , Adult , Aged , Anticoagulants/therapeutic use , Clopidogrel , Diagnosis, Differential , Diffusion Magnetic Resonance Imaging , Female , Hemianopsia/etiology , Heparin/therapeutic use , Humans , Infarction, Posterior Cerebral Artery/complications , Infarction, Posterior Cerebral Artery/drug therapy , Magnetic Resonance Angiography , Male , Migraine Disorders/diagnosis , Nimodipine/therapeutic use , Recurrence , Ticlopidine/analogs & derivatives , Ticlopidine/therapeutic use , Vasodilator Agents/therapeutic use , Vasospasm, Intracranial/complications , Vasospasm, Intracranial/diagnosis , Vasospasm, Intracranial/drug therapy
2.
Homeopathy ; 97(4): 206-13, 2008 Oct.
Article in English | MEDLINE | ID: mdl-19371570

ABSTRACT

Homeopathy has been used for more than two hundred years to treat chronic disease using various approaches in a wide range of diseases. However, for acute disease and critical illness, application has been limited by inadequate training of homeopathic physicians and the small number of pertinent clinical studies. In view of the difficulty of practising homeopathy in Intensive Care Units (ICU), a protocol was developed to facilitate description of objective homeopathic symptoms with a ranking of symptoms appropriate for these situations (Protocol for Objective Homeopathic Semiology). Examples of favorable results with individualized homeopathic treatments for a series of cases of Systemic Inflammatory Response Syndrome (sepsis) are described.


Subject(s)
Acute Disease , Homeopathy/methods , Intensive Care Units , Sepsis/therapy , Aged , Female , History, Ancient , Homeopathy/history , Humans
3.
J Neurol Neurosurg Psychiatry ; 75(11): 1611-3, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15489397

ABSTRACT

Brain involvement in myotonic dystrophy type 1 (DM1) is characterised by cortical atrophy and white matter lesions. We compared the magnetic resonance imaging derived grey matter maps of 22 DM1 patients with those of matched, healthy controls using voxel based morphometry to evaluate the extension of global and regional cortical atrophy in DM1, as well as its relationships with clinical and genetic features. Patients had significantly reduced brain tissue volumes. Grey matter volume was inversely correlated with age; this inverse correlation was significantly stronger in DM1 than in controls. Neither the clinical and genetic characteristics nor white matter lesions were correlated with cortical atrophy. Grey matter atrophy was located mainly in the bilateral frontal and parietal lobes, in the bilateral middle temporal gyrus, and in the left superior temporal and occipital gyrus.


Subject(s)
Cerebral Cortex/pathology , Image Processing, Computer-Assisted , Imaging, Three-Dimensional , Magnetic Resonance Imaging , Myotonic Dystrophy/diagnosis , Adult , Atrophy , Brain Mapping , Chromosome Aberrations , Chromosomes, Human, Pair 19 , Disease Progression , Female , Genes, Dominant/genetics , Humans , Male , Mathematical Computing , Middle Aged , Myotonic Dystrophy/genetics , Neurologic Examination , Reference Values , Software , Trinucleotide Repeats/genetics
4.
J Neurol Neurosurg Psychiatry ; 74(7): 998-9, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12810806

ABSTRACT

The cause of downbeat nystagmus (DBN) remains undiagnosed in about 40% of patients. This paper reports the presence of antiglutamic acid decarboxylase antibodies (GAD-Ab) in a patient with DBN. Antibodies against GABAergic neurons located in the vestibular complex may induce chemical denervation of the floccular neurons, which normally suppress the peripheral imbalance between vertical semicircular canal systems, thereby causing DBN. Testing for GAD-Ab may be indicated in DBN patients without an identifiable anatomical brain lesion.


Subject(s)
Autoantibodies/immunology , Glutamate Decarboxylase/immunology , Nystagmus, Pathologic/immunology , Aged , Autoantibodies/analysis , Female , Humans , Nystagmus, Pathologic/pathology , Receptors, GABA-A/physiology
5.
Neurology ; 57(6): 1126-8, 2001 Sep 25.
Article in English | MEDLINE | ID: mdl-11571352

ABSTRACT

To detect signs of axonal damage in MS, the authors investigated the occurrence in EMG of motor unit action potentials with satellite potentials (SP-MUAP) in the upper limb muscles in 10 consecutive patients with MS with cervical spinal cord demyelinating lesions and 10 control subjects. Subjects' SP-MUAP rate was 0 to 2.5% (median 0%) in the control group, and 0 to 17.5% (median 7.5%) in the MS group (p < 0.01). Motor unit remodeling secondary to axonal transection of spinal motor neurons traversing cervical demyelinating lesions may be hypothesized.


Subject(s)
Axons/physiology , Electromyography , Multiple Sclerosis/physiopathology , Adult , Evoked Potentials, Motor/physiology , Female , Humans , Middle Aged , Motor Neurons/physiology , Multiple Sclerosis/diagnosis , Muscle, Skeletal/innervation , Spinal Cord/physiopathology , Wallerian Degeneration/diagnosis , Wallerian Degeneration/physiopathology
6.
Muscle Nerve ; 23(2): 252-8, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10639619

ABSTRACT

Spinal-bulbar muscular atrophy (SBMA) is a rare X-linked neuronopathy associated with an abnormal representation of androgen receptors in the nervous system. Standard nerve conduction and histopathological studies have disclosed the involvement of large myelinated sensory fibers in the spinal nerves of SBMA patients. Little is known about the involvement of small sensory neurons and trigeminal nerves. Laser evoked potentials (LEPs) were studied in 6 unrelated patients with SBMA; 5 of these patients also underwent trigeminal reflex recordings, and 3 a sural nerve biopsy. LEPs were markedly abnormal, indicating a dysfunction in pain pathways. Given the sparing of small fibers in the sural nerve specimens, we hypothesize a dysfunction in spinothalamic cells, possibly due to an abnormal representation of the androgen receptors. Except for the jaw-jerk, all the trigeminal reflexes were markedly abnormal. Since the afferents for the jaw-jerk have their cell body within the central nervous system instead of the ganglion, the selective sparing of the jaw-jerk indicates a trigeminal ganglionopathy.


Subject(s)
Hereditary Sensory and Motor Neuropathy/physiopathology , Muscular Atrophy, Spinal/physiopathology , Nerve Fibers, Myelinated/physiology , Aged , Electrodiagnosis , Electromyography , Evoked Potentials/physiology , Hereditary Sensory and Motor Neuropathy/genetics , Hereditary Sensory and Motor Neuropathy/pathology , Humans , Male , Middle Aged , Muscular Atrophy, Spinal/genetics , Muscular Atrophy, Spinal/pathology , Neural Conduction/physiology , Reflex/physiology , Sural Nerve/pathology , Trigeminal Ganglion/physiopathology
7.
Neurology ; 50(5): 1441-5, 1998 May.
Article in English | MEDLINE | ID: mdl-9596002

ABSTRACT

BACKGROUND: Bone marrow transplant (BMT) is used for both neoplastic and nonneoplastic diseases. Following BMT, particularly during the first 3 months, patients have a number of neurologic complications. We evaluated the early neurologic complications following BMT and their influence on survival. METHODS: We prospectively followed 115 consecutive patients having BMT for leukemia, for a median period of 90 days after transplantation. RESULTS: Sixty-four patients (56%) had neurologic complications. Sixteen developed more than one complication. Twenty-seven patients (25%) had major neurologic complications: metabolic encephalopathy (8), seizures (8), psychiatric symptoms (3), cerebral hemorrhage (1), cerebral abscess (1), leukemic meningitis (1), peripheral neuropathies (5), and myopathies (2). Forty patients (35%) had minor complications, including headache (16) and tremor (31). Major neurologic complications occurred after engraftment in most patients. Metabolic encephalopathy correlated with graft-versus-host disease (GVHD) (p < 0.03). Seven percent of patients had generalized seizures that occurred without signs of structural cerebral lesions. Probability of survival at day 90 was lower in patients with than in those without major central nervous system complications (63% versus 87.5%, p < 0.01). CONCLUSIONS: Neurologic complications are frequent during the first 3 months following BMT and affect patient survival. Drug neurotoxicity and acute GVHD are the main factors influencing their occurrence.


Subject(s)
Bone Marrow Transplantation/adverse effects , Central Nervous System Diseases/etiology , Leukemia/therapy , Peripheral Nervous System Diseases/etiology , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Leukemia/complications , Leukemia/mortality , Male , Middle Aged , Prospective Studies , Survival Rate , Time Factors , Transplantation, Homologous , Treatment Outcome
9.
Stroke ; 28(1): 10-4, 1997 Jan.
Article in English | MEDLINE | ID: mdl-8996480

ABSTRACT

BACKGROUND AND PURPOSE: Our aims were to identify predictors of early neurological improvement in acute ischemic stroke patients, to evaluate its impact on clinical outcome, and to investigate possible mechanisms. METHODS: A consecutive series of 152 first-ever ischemic hemispheric stroke patients hospitalized within 5 hours of onset underwent a first CT scan within 1 hour of hospitalization, and the initial subset of 80 patients also underwent angiography. During the first 48 hours of hospital stay, an increase or a decrease of 1 or more points in the admission Canadian Neurological Scale (CNS) score was defined as early improvement or early deterioration, respectively. Repeated CT scan or autopsy was performed 5 to 9 days after stroke. RESULTS: Thirty-four patients (22%) improved, 84 (56%) remained stable, and 34 (22%) deteriorated. Logistic regression, which took into account vascular risk factors, baseline clinical and CT data, and therapies administered, selected younger age, lower admission CNS score, and absence of early hypodensity at first CT as independent predictors of early improvement. Among the patients who underwent angiography, logistic regression selected arterial patency and presence of collateral blood supply as independent predictors of early improvement. At the repeated CT scan or autopsy, improving patients presented the highest frequency of small infarcts. Thirty-day case-fatality rate and disability were lower in improving patients. Variables independently associated with outcome at logistic regression were admission CNS score, early deterioration, and early improvement. CONCLUSIONS: Early improvement can be predicted by the absence of early CT hypodensity and is highly predictive of good outcome. Presence of collateral blood supply and presumably early spontaneous recanalization are likely to be the mechanisms underlying early improvement.


Subject(s)
Brain Ischemia/therapy , Aged , Analysis of Variance , Brain Ischemia/diagnostic imaging , Brain Ischemia/physiopathology , Cerebral Angiography , Cerebral Infarction/diagnostic imaging , Cerebral Infarction/physiopathology , Disease Progression , Female , Humans , Male , Middle Aged , Odds Ratio , Regression Analysis , Reproducibility of Results , Risk Factors , Tomography, X-Ray Computed , Treatment Outcome
10.
J Neurol Sci ; 144(1-2): 212-3, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8994126

ABSTRACT

A case of reversible encephalopathy during treatment with Amphotericin-B (AMB) is described. The comparison of the clinical course of AMB encephalopathy with total dose of AMB, cranial radiotherapy and MRI data available in previously reported cases, shows that this complication is characterized by a progressive, dose-dependent course, possibly influenced by cranial irradiation.


Subject(s)
Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Leukoencephalopathy, Progressive Multifocal/drug therapy , Dose-Response Relationship, Drug , Humans , Male , Middle Aged , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...